dPCR and qPCR Market Trends 2020, Global Size, Growing Demand, Regional Analysis, Competitive Landscape
                     dPCR and qPCR Market
dPCR and qPCR are PCR technology which 
have evolved over the years from 
thermostable polymerases, development 
of automated thermocyclers to latest 
digital PCR (d-PCR) methodologies. 
However, the basic principle of denature, 
anneal, extend remains the same. qPCR has 
spawned the second generation that allows 
analysis and diagnosis with reduced risk of 
contamination and is considered as ‘gold 
standard’. dPCR amplifies the target DNA 
molecule and quantifies directly without 
external calibrator. 
dPCR and qPCR Market
Current and future Market Scenario
 The dPCR and qPCR in healthcare market was valued at US$ 3,255.5 million in 2017 and it is projected to reach 
US$ 6,371.6 million by 2025; it is expected to grow at a CAGR of 9.1% from 2018 to 2025.
 The growth of the dPCR and qPCR in healthcare market is attributed to the Increasing Incidence of Genetic Diseases, 
Increase in Investments & Funds for Gene Synthesis, Technological Advancements in PCR Technologies are key drivers for 
the growth of the market.
 High Costs of PCR Systems and Technical Limitations Associated with qPCR are likely to restrain the market growth to a 
certain extent.
 The dPCR and qPCR in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has 
affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns.
Key Findings
 The key findings and recommendations highlight crucial progressive industry trends in the global dPCR and qPCR 
market, thereby allowing players across the value chain to develop effective long-term strategies.
 Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in 
the dPCR and qPCR market.
 Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Market Insights
Growing Applications of DPCR and qPCR in Healthcare to Drive DPCR and qPCR in Healthcare Market Growth
Genes are considered to be the building blocks of heredity. The genes are passed from a parent to a child, as well as they 
hold the DNA that is usually considered to instruct and guide protein synthesis. Mutation, on the other hand refers to a 
sudden change in a single or multiple genes. The mutation can result in dysfunction of the gene resulting in a medical 
condition called genetic disorder. According to the National organizations information on genetic conditions or birth 
defects, though individual genetic disorders are rare, collectively they comprise over 15,500 recognized genetic disorders. 
dPCR and qPCR Market
Market Segments
by Product by Application
by Technology
(Reagents & Consumables (Research Application
(Quantitative PCR (qPCR) Instruments Clinical Application
Digital PCR (dPCR)  Software & Services) Forensic Application)
dPCR and qPCR Market
Dominating Segments
 Gene synthesis is mostly accepted tool in fields of recombinant DNA technology, which includes recombinant 
protein production and PCR technology for amplification as well as quantification purposes.
 the gene synthesis has set benchmark with its innovations and the dynamic results. The industry has 
attracted various global leaders to invest for gene synthesis.
 The PCR technology is like the sunrise sector in the global healthcare and analytics arena. The growing 
inventions and innovation in the sector have continuing to accelerate worldwide.
 PCR is a nearly ubiquitous, powerful and reliable technology found in most molecular biology labs to amplify 
specific stretches of DNA for genotyping, cloning, analysis of single nucleotide variations and even serves as 
the basis for most next-generation sequencing (NGS) preparation.
Dominating Segments
 Technology-Based Insights
The Quantitative PCR (qPCR) held the major market share among the technology segment
In 2017, the Quantitative PCR (qPCR) segment held a largest market share of 55.9% of the dPCR and qPCR market, by 
technology. This segment is also expected to dominate the market in 2025 owing to its improved sensitivity, rapidity 
and reproducibility. It allows cost effective analysis with inexpensive kits and reagents. Furthermore, the digital PCR 
segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.
 
 Application-Based Insights
The research application segment is expected to dominate the market based on application
The research application segment is anticipated to grow at a CAGR of 9.4% during the forecast period. The increasing 
adoption of dPCR and qPCR technology in research activities in virology, bacteriology, oncology, parasitology and 
biotechnology drives the market growth.
 Get Sample Copy Click Here:  https://bit.ly/3y9RHGI 
Dominating Segments
DPCR and qPCR in Healthcare Market – by Technology
Quantitative PCR (qPCR)
Digital PCR (dPCR)
DPCR and qPCR in Healthcare Market – by Product
Reagents & Consumables
Instruments
 Software & Services
Dominating Segments
DPCR and qPCR in Healthcare Market – by Application
Research Application
Clinical Application
Forensic Application
dPCR and qPCR Market
Leading Players
Company Profiles in dPCR and qPCR  Market are:
F. Hoffmann-La Roche Ltd
 Thermo Fisher Scientific, Inc.
 Bio-Rad Laboratories, Inc.
 Qiagen N.V.
 Takara Bio, Inc.
 Agilent Technologies, Inc.
 Biomérieux S.A.
 Fluidigm Corporation
 Danaher Corporation
 ABBott Laboratories
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
  dPCR and qPCR Market
 
 
 
dPCR and qPCR Market
 
 
        
Access Full Research Report at: 
https://bit.ly/3f0ztjx   
 
Thank You! 
Thank You!